Mustang BioMBIO

13F holders, Q3 2025 (September 30)
20holders +3
6new positions
2sold out
1famous investor
$1.52avg. 13F price*

At the end of Q3 2025, 20 institutions reported holding Mustang Bio Inc. (MBIO) in their 13F filings, up 3 from Q2 2025. 6 opened new positions and 2 sold out. The largest holders were BlackRock, Inc. ($129K), Kestra Advisory Services, LLC ($100K) and Vanguard Group Inc. ($88K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Mustang Bio Inc.
CUSIP
62818Q302
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q4 2024: 1Q4 2024Q1 2025: 16Q1 2025Q2 2025: 17Q2 2025Q3 2025: 20Q3 2025Q4 2025: 25Q4 2025Q1 2026: 22Q1 2026Q2 2026: 23Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions6$251K
Exits2$27K

All 13F filers, Q2 2025 → Q3 2025: 260,016 shares bought and 53,674 shares sold, net +206,342 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 20 holders

BlackRock, Inc. 0.00% Add +4989.8% 84,745 $129K
Kestra Advisory Services, LLC 0.00% New 66,108 $100K
Vanguard Group Inc. 0.00% New 57,863 $88K
Geode Capital Management, LLC 0.00% Add +64.3% 26,418 $40K
XTX Topco Ltd 0.00% New 18,775 $29K
Renaissance Technologies 0.00% New 11,800 $18K
CFO4Life Group, LLC 0.00% New 10,461 $16K
SBI Securities Co., Ltd. 0.00% Add +299.8% 2,007 $3K
Tower Research Capital LLC (TRC) 0.00% Reduce -66.5% 1,332 $2K
Citigroup Inc. 0.00% Reduce -40.2% 602 $915
Morgan Stanley 0.00% Add +27.9% 303 $461
Harbour Investments, Inc. 0.00% No change 76 $116
Bank of America Corp. 0.00% Add +57.6% 52 $79
UBS Group AG 0.00% Reduce -99.8% 48 $73
BNP Paribas Financial Markets 0.00% No change 6 $9
Lanark Financial, Inc. 0.00% New 3 $4
JPMorgan Chase & Co. 0.00% No change 2 $3
Danske Bank A/S 0.00% No change 2 $3
Group One Trading LLC 0.00% No change 1 $2
Cwm, LLC 0.00% No change 2 $0

"% of holder's portfolio" is MBIO's weight in each manager's 13F, not the share of Mustang Bio Inc. the manager owns.